Fluor announced that a groundbreaking event was held for Bayer’s first-of-a-kind cell culture technology center in Berkeley, California. The engineering company is providing a single point of responsibility for engineering, procurement, construction management and commissioning, qualification and validation of the facility that will produce oncology and other therapeutics.
Berkeley/USA — The state-of-the-art Single Use Technology (SUT) biopharmaceutical manufacturing facility will be constructed at Bayer’s Berkeley site using land from a demolished office building. In 2018, Fluor engaged in the conceptual study and front-end engineering design for the project which is due for completion in early 2021.
Bayer selected GE Healthcare to provide its Flex Factory SUT platform which will be incorporated into the project through a collaborative subcontract to the engineering company. GE Healthcare is supplying all major unit operations, systems and ancillary equipment and components.
Fluor’s scope also includes process integration for the entire facility and all associated utilities. Their San Francisco office will lead the project with support from the company’s offices in Greenville, South Carolina and Gliwice, Poland.